Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST)

Annals of Epidemiology

Volumn 6, Issue 2, 1996, Pages 93-101

  Obias Manno, Dulce ^a   Friedmann, Erika ^g   Brooks, Maria Mori ^b   Thomas, Sue A ^c   Haakenson, Clair ^d   Morris, Mary ^g   Wimbush, Frances ^g   Somelofski, Carolyn ^e   Goldner, Francie ^f  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Life Care Health Foundation   (United States)

^d Coop Studs Prog Clin Res P ^*  (United States)

^e SAN FRANCISCO GENERAL HOSPITAL   (United States)

^f VANDERBILT UNIVERSITY   (United States)

^g NONE

Author keywords

clinical trials; Coronary heart disease; drug adherence; medication compliance; myocardial infarction; survival; treatment efficacy

Indexed keywords

ENCAINIDE; FLECAINIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SURVIVAL;

EID: 0030005030     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/1047-2797(95)00134-4     Document Type: Article

References (18)

1. Goldman AI, Holcomb R, Perry HM Jr, Schnaper HW, Fitz AE, Frohlich ED. Can dropout and other noncompliance be minimized in a clinical trial?, Controlled Clin Trials. 1982;3:7589.
2. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project, N Engl J Med. 1980;303:1038-1041.
3. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes, Arch Intern Med. 1993;153:1863-1868.
4. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial, N Engl J Med. 1991;324:781-788.
5. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
6. Pratt CM, Moye LA. The Cardiac Arrhythmia Suppression Trial: Background, interim results and implications. Am J Cardiol. 1990; 65:25B-29B.
7. Feinstein AR. Compliance bias and the interpretation of therapeutic trials. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins Univ. Press; 1979:309-322.
8. May GS, Geraci B., DeMets DL, Friedman LM, Furberg C, Passamani E. The randomized clinical trial: Bias in analysis, Circulation. 1981; 64:669-673.
9. Goldsmith CH. The effect of compliance distribution on therapeutic trials. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins Univ. Press; 1979:297-308.
10. The CAPS Investigators. The Cardiac Arrhythmia Pilot Study, Am J Cardiol. 1986;54:91-95.
11. Black DM, Brand RJ, Greenlick M., Hughes G, Smith J, for the SHEP Pilot Research Group. Compliance to treatment for hypertension in elderly patients: The SHEP Pilot Study, J Gerontol. 1987;42:552-557.
12. Gordis L. Conceptual and methodologic problems in measuring patient compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins Univ. Press; 1979: 23-45.
13. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets?, Clin Pharmacol Ther. 1989;46:163-168.
14. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: Applications in an ambulatory hypertensive drug trial, Clin Pharmacol Ther. 1990;48:676-685.
15. Brittan E, Wilter J. The run-in period in clinical trials: The effect of misclassification on efficiency, Controlled Clin Trials. 1990;11:327-338.
16. Manolio TA, Furberg CD. Epidemiology of sudden cardiac death. In: Akntar M, ed. Sudden Cardiac Death. Malvern, PA: Williams & Wilkins; 1994:3-20.
17. Osswald S, Trouton TG, O'Nunain S, Ruskin JN. Patients with cardiac arrest and documented ventricular fibrillation. In: Akntar M, ed. Sudden Cardiac Death. Malvern, PA: Williams & Wilkins; 1994:465-485.
18. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines, Br J Gen Pract. 1990;40:114-115.